SPARC enters pact with University of California, San Francisco, Tiller Therapeutics for Pre-clinical Oncology asset Ruchika Sharma20 Dec 2024 1:30 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) has announced the signing of a binding Letter of Intent (LOI) with the University of...
Sun Pharma Advanced Research Company halts Parkinson's disease drug trial Ruchika Sharma10 April 2024 2:42 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) today announced results of interim analysis from the PROSEEK study, a global,...
SPARC announces retirement of Dr Chitturi Trinadha Rao - Senior Vice President, Drug Discovery Ruchika Sharma3 Nov 2023 1:30 PM ISTMumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced that Dr Chitturi Trinadha Rao – Senior Vice President, Drug Discovery,...
SPARC enters into an exclusive worldwide license agreement with Johns Hopkins University, IOCB for hair loss drug Ruchika Sharma3 Nov 2023 12:30 PM ISTSCD-153 is a first-in-class topical drug for the treatment of alopecia areata developed jointly by SPARC, JHU and IOCB.
SPARC concludes enrolment in global Phase 2 study of Vodobatinib in early Parkinson's disease Ruchika Sharma30 Oct 2023 11:30 AM ISTVodobatinib is a potential first-in-class, highly selective and brain penetrating c-Abl inhibitor.
Sun Pharma Advanced Research net loss widens to Rs 81.99 crore in Q4 Ruchika Sharma22 May 2023 4:30 PM ISTNew Delhi: Sun Pharma Advanced Research Company Ltd on Monday said its net loss widened to Rs 81.99 crore in the fourth quarter ended March 2023,...
Sun Pharma gets USFDA nod for neonatal seizures treatment SEZABY Ruchika Sharma18 Nov 2022 12:15 PM ISTSEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection.
SPARC licenses PDP-716, SDN-037 drug rights to Visiox Pharma Ruchika Sharma8 Dec 2021 1:20 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) today announced that the company has entered into an agreement with Visiox Pharma LLC...
SPARC, Biomodifying ink antibody licensing agreement Ruchika Sharma4 Dec 2021 1:11 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) has recently announced that the company has entered into an agreement with Biomodifying LLC...
Appointment of Anilkumar Raghavan as CEO gets SPARC shareholders nod Ruchika Sharma1 Oct 2021 4:29 PM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Thursday said its shareholders have approved the appointment of Anilkumar Raghavan as chief...
Sun Pharma Advanced Research Company to raise up to Rs 1800 crore Medical Dialogues Team2 Sept 2021 9:00 AM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Wednesday said it will seek shareholders' approval to raise up to Rs 1,800 crore through...
SPARC appoints Anil Raghavan as new CEO, Dilip Shanghvi resigns as MD Ruchika Sharma26 May 2021 1:48 PM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Tuesday said Dilip Shanghvi has resigned as managing director of the company.Shanghvi...
